Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.

The combination of tamoxifen and transdermal hormone replacement therapy (HRT) may potentially reduce risks and side-effects of either agent, but an adverse interaction could attenuate their beneficial effects. We assessed the effects of their combination on cardiovascular risk factors within a prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Decensi, A., Robertson, C., Rotmensz, N., Severi, G., Maisonneuve, P., Sacchini, V., Boyle, P., Costa, A., Veronesi, U.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063049/
https://www.ncbi.nlm.nih.gov/pubmed/9744493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063049/
https://www.ncbi.nlm.nih.gov/pubmed/9744493

Ejemplares similares